comparemela.com

Latest Breaking News On - Tandem diabetes care company profile - Page 2 : comparemela.com

Tandem Diabetes Care (NASDAQ:TNDM) Earns Overweight Rating from Piper Sandler

Tandem Diabetes Care (NASDAQ:TNDM – Get Free Report)‘s stock had its “overweight” rating restated by investment analysts at Piper Sandler in a research report issued to clients and investors on Friday, Benzinga reports. They presently have a $50.00 price objective on the medical device company’s stock, up from their previous price objective of $35.00. Piper […]

Jennison Associates LLC Purchases 167,675 Shares of Tandem Diabetes Care, Inc (NASDAQ:TNDM)

Jennison Associates LLC Purchases 167,675 Shares of Tandem Diabetes Care, Inc (NASDAQ:TNDM)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Tandem Diabetes Care (NASDAQ:TNDM) Shares Up 7 9%

Tandem Diabetes Care (NASDAQ:TNDM) Shares Up 7 9%
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Tandem Diabetes Care (NASDAQ:TNDM) Stock Price Up 7 9%

Tandem Diabetes Care (NASDAQ:TNDM) Stock Price Up 7 9%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Tandem Diabetes Care (NASDAQ:TNDM) Price Target Raised to $38 00

Tandem Diabetes Care (NASDAQ:TNDM – Get Free Report) had its price objective lifted by Citigroup from $31.00 to $38.00 in a report released on Wednesday, Benzinga reports. The brokerage currently has a “neutral” rating on the medical device company’s stock. Citigroup’s price target indicates a potential upside of 9.86% from the stock’s previous close. Several […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.